This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: Q24.4 | Special Copayment Reduction: V270 (rare disease) |
| B. Synonyms | Congenital subaortic stenosis |
| C. Adult onset | Likelihood of first presentation in adulthood: low to moderate — fixed subvalvular stenosis is often detected in childhood, but a mild fibromuscular ridge may first be detected as a heart murmur in adulthood. |
| 1. History | First described by Chevers in 1842; surgical resection standardized since the 1960s; recurrence is the main clinical challenge. |
| 2. Causes | Formation of a fibromuscular membrane or ridge in the left ventricular outflow tract; tunnel-type stenosis; may be accompanied by Shone complex. |
| 3. Genetics | Mostly sporadic; some familial clustering reported; a PTPN11 (Noonan syndrome)-associated form exists. |
| 4. General epidemiology | About 1% of all congenital heart malformations; about 8–20% of left ventricular outflow tract obstructions; male predominance (about 2:1). |
| 5. Pathophysiology | Fibrous membrane obstructs the LVOT → left ventricular pressure overload → concentric hypertrophy; turbulence damages the aortic valve, causing AR. |
| 6. Symptoms | Heart murmur in childhood; if moderate or worse, exercise intolerance, angina, syncope; with AR, additional regurgitation symptoms. |
| 7. Signs | Systolic ejection murmur at the left sternal border; no aortic ejection sound (subvalvular feature); diastolic murmur with AR; left ventricular hypertrophy. |
| 8. Screening | Echocardiography for evaluation of childhood heart murmurs; screening for Shone complex; follow-up for postoperative recurrence. |
| 9. Diagnosis | Echocardiography (Doppler pressure gradient, membrane visualization); CMR; cardiac catheterization if needed before surgery. |
| 10. Treatment | Surgical membrane resection + ventricular septal myectomy (extended resection) is standard; reoperation for recurrence; concomitant valve repair if AR progresses. |
| 11. Prognosis | Good improvement in pressure gradient after surgery; recurrence rate 10–30%; prevention of AR is the key reason for early surgery. |
| 12. Prevention | Prevention of AR by early surgery; regular postoperative follow-up (surveillance for recurrence); endocarditis prophylaxis; exercise restriction. |
| 13. References | 10 major clinical guidelines and original papers |
Congenital Subaortic Stenosis was first described at autopsy by Chevers in 1842, and in the late 19th century several anatomists subsequently reported various forms of obstruction below the valve. Clinically it was difficult to distinguish from valvular stenosis, but with the development of cardiac catheterization and echocardiography in the mid-20th century, subvalvular stenosis was established as an independent clinical entity.
As open-heart surgery became standardized in the 1960s, resection of the fibromuscular ridge or discrete membrane became the core of surgical treatment. Initially only simple membrane resection was performed, but because of high recurrence rates, extended resection combined with septal myectomy subsequently became standard. Long-term follow-up studies showed that the recurrence rate reaches 10–30% even after surgery, so a considerable number of patients require repeat surgery. The recognition of aortic regurgitation (AR) as an important associated complication of subvalvular stenosis is also an achievement of modern medicine.
Recently, evidence has been accumulating that preoperative prophylactic resection (surgery when the pressure gradient exceeds a certain threshold even without symptoms) is effective in preventing aortic regurgitation.
The anatomical causes of congenital subaortic stenosis are broadly classified into three types.
Discrete fibrous membrane: the most common type, in which a fibrous or fibromuscular membrane forms in the left ventricular outflow tract (LVOT) and partially or completely obstructs the outflow tract just below the aortic valve. The membrane usually originates between the anterior mitral leaflet and the ventricular septum and crosses all or part of the outflow tract.
Tunnel-type subaortic stenosis: rarer than membranous stenosis but more severe, with tubular narrowing formed along the entire length of the left ventricular outflow tract. Surgical correction is more complex.
Complex type and associated malformations: Shone complex (associated with mitral stenosis, parachute mitral valve, and coarctation of the aorta), ventricular septal defect (VSD), coarctation of the aorta, and aortic valve dysplasia are common associated malformations.
Embryologically, there is a theory that hemodynamic abnormalities (turbulence) in the left ventricular outflow tract stimulate fibroblasts and promote membrane formation. This is consistent with the clinical observation that most subvalvular stenoses are not present at birth and develop gradually after birth.
Most congenital subaortic stenosis occurs sporadically, and no single causative gene has yet been established. However, some familial clustering has been reported, suggesting a genetic predisposition.
Noonan syndrome: a syndrome caused by mutations in RAS/MAPK pathway genes such as PTPN11 (12q24.13), RAF1, and SOS1, in which dynamic outflow tract obstruction or fixed subvalvular stenosis may appear together with hypertrophic cardiomyopathy (HCM). Pulmonary stenosis or hypertrophic cardiomyopathy accompanies about 20–30% of patients with Noonan syndrome, and subvalvular stenosis has also been reported in some.
Other associated syndromes include Williams syndrome (ELN gene deletion; mainly supravalvular stenosis, but may be accompanied by subvalvular stenosis) and DiGeorge syndrome (22q11.2 deletion, CATCH-22). When multiple heart malformations are present or a syndrome is suspected, chromosomal microarray or whole-exome analysis is considered.
Congenital subaortic stenosis accounts for about 1% of all congenital heart malformations and is the most common cause of left ventricular outflow tract obstruction (LVOTO) after aortic valve stenosis. About 8–20% of all left ventricular outflow tract obstructions are subvalvular stenosis.
It occurs more often in males, at a ratio of about 2:1. By age, some patients are diagnosed in childhood, and mild membranous stenosis is sometimes first detected in adulthood. Discrete membranous stenosis is much more common than the tunnel type (about 70–80%), and the tunnel type requires more complex surgery.
In Korea, it is managed in pediatric cardiology and adult congenital heart disease clinics under Special Copayment Reduction (V270) registration, and follow-up for postoperative recurrence is an important clinical task.
The core pathophysiology of congenital subaortic stenosis is left ventricular pressure overload due to fixed left ventricular outflow tract obstruction (fixed LVOTO). The fibrous membrane or ridge narrows the outflow tract, increasing flow velocity, and a left ventricular–aortic systolic gradient develops.
As compensation for pressure overload, left ventricular concentric hypertrophy develops. If severe stenosis persists, it progresses to diastolic dysfunction and then to reduced systolic function.
Mechanism of aortic regurgitation (AR): high-velocity turbulent flow arising from the subvalvular stenosis repeatedly strikes the undersurface of the aortic valve, causing aortic valve endothelial injury, leaflet thickening, and progressive regurgitation. This means that if the stenosis is not corrected surgically early, it can lead to irreversible valve damage. Aortic regurgitation adds an additional volume load to the left ventricle, worsening the condition.
Mild: often asymptomatic, with detection of a heart murmur as the first clue. Some patients remain asymptomatic with a mild pressure gradient into adulthood.
Moderate to severe: the classic triad similar to aortic valve stenosis (angina, syncope, heart failure) may occur. Dyspnea, chest pain, and dizziness on exertion appear, and in severe cases there is a risk of syncope or sudden death. In children, reduced exercise capacity and poor growth may occur.
With aortic regurgitation (AR): symptoms of left ventricular volume overload due to diastolic regurgitation (exercise intolerance, dyspnea) are added.
With complicating endocarditis: fever, chills, a new murmur, and embolic symptoms appear. Discrete membranous stenosis is a vulnerable site for endocarditis.
Auscultation: an ejection systolic murmur is heard at the 3rd–4th intercostal spaces at the left sternal border. As an important differentiating point, unlike aortic valve stenosis, there is no ejection click (because the valve itself is normal or only secondarily damaged). The murmur radiates to the neck, and in severe cases a thrill is palpable at the suprasternal area. With AR, a diastolic regurgitant murmur at the left sternal border is added.
Electrocardiogram: findings of left ventricular hypertrophy (left axis deviation, high voltage in V5-V6, strain pattern) appear. It may be normal in mild cases.
Chest X-ray: left ventricular hypertrophy and poststenotic dilation of the ascending aorta may also appear in subvalvular stenosis.
Universal screening for congenital subaortic stenosis is not performed. Detection of a heart murmur in childhood is the main trigger for diagnosis.
Echocardiography for childhood heart murmurs: in children with an abnormal heart murmur, echocardiography confirms whether subvalvular stenosis is present. Membranous stenosis is visualized as an echo density just below the aortic valve.
Screening for Shone complex: when subvalvular stenosis is found, associated malformations of the mitral valve, aortic valve, and coarctation of the aorta are fully evaluated.
Postoperative follow-up: because recurrence after resection reaches 10–30%, restenosis is followed with regular echocardiography (every 1–2 years). Progression of aortic regurgitation is monitored concurrently.
Echocardiography: the standard for diagnosis. In the long-axis view, the fibrous membrane or ridge below the aortic valve is visualized as an echo density. Color Doppler confirms accelerated flow at the stenosis, and continuous-wave Doppler measures the peak and mean pressure gradients. The presence and severity of aortic regurgitation are also assessed. Assessment of left ventricular size and function is also essential. Severity criteria: a peak pressure gradient >64 mmHg or a mean pressure gradient >40 mmHg is classified as severe.
Cardiac MRI (CMR): useful for detailed anatomical evaluation, precise measurement of left ventricular function, and calculation of AR fraction.
Exercise stress testing: used in asymptomatic moderate cases to assess exercise-induced symptoms and abnormal blood pressure responses.
Cardiac catheterization: performed when noninvasive evaluation is insufficient or for preoperative coronary angiography.
Indications for surgery: ① peak pressure gradient >50 mmHg (or mean >30 mmHg) + symptoms or AR progression ② AR progressing to moderate or worse even if the pressure gradient is low ③ moderate or worse stenosis when other cardiac surgery (VSD repair, etc.) is performed ④ some guidelines recommend prophylactic surgery to prevent AR if the pressure gradient is >30 mmHg even when asymptomatic.
Surgical resection: extended resection combining fibromuscular resection under direct vision with septal myectomy is standard. Simple membrane resection alone has a high recurrence rate (about 20–30%). Reoperation is required for recurrence, and the risk of repeat surgery accumulates.
Tunnel-type stenosis: requires the Konno procedure (aortic annular enlargement, aortico-ventriculoplasty), which is technically complex.
With AR: when severe AR is present, aortic valve repair or replacement is performed concurrently.
The short-term postoperative prognosis of congenital subaortic stenosis is good, with a surgical mortality of 1–3% in specialized centers. However, restenosis on long-term follow-up is the main clinical challenge.
Restenosis: the 10-year freedom from reoperation after extended resection is about 70–80%. Risk factors for restenosis are younger age, larger initial pressure gradient, and more complex associated malformations. Recurrence is followed with regular postoperative echocardiography (every 1–2 years).
Aortic regurgitation (AR): when there is no or only mild AR before surgery, early surgery can prevent AR progression. When severe AR is present before surgery, the valve damage may be irreversible. If AR progresses over the long term, additional valve surgery is required.
Infective endocarditis: because dysplastic structures remain even after surgery, the risk of endocarditis persists. Prophylactic antibiotic guidelines are followed.
Primary prevention of congenital subaortic stenosis itself is not possible.
Prevention of AR by early surgery: in an already identified stenosis, performing surgery before AR progresses (at the stage of mild AR or before AR develops) can prevent aortic valve damage. Some guidelines recommend surgery to prevent AR if the pressure gradient is >30 mmHg.
Regular postoperative follow-up: echocardiography every 1–2 years for surveillance of restenosis, monitoring of AR progression.
Prevention of infective endocarditis: prophylactic antibiotics before invasive procedures in high-risk groups.
Exercise restriction: high-intensity competitive sports and isometric exercise are restricted in moderate or worse stenosis.
Cape EG, Vanauker MD, Sigfusson G, Tacy TA, del Nido PJ. Potential role of mechanical stress in the etiology of pediatric heart disease: septal shear stress in subaortic stenosis. J Am Coll Cardiol. 1997;30(1):247-254. DOI: 10.1016/S0735-1097(97)00106-3. PMID: 9207650.
Brauner RA, Laks H, Drinkwater DC Jr, Scholl F, McCaffery S. Multiple left heart obstructions (Shone's anomaly) with mitral valve involvement: long-term surgical outcome. Ann Thorac Surg. 1997;64(3):721-729. PMID: 9307464.
Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for adult congenital heart disease. Eur Heart J. 2021;42(6):563-645. DOI: 10.1093/eurheartj/ehaa554. PMID: 32860028.
Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for Adults with Congenital Heart Disease. J Am Coll Cardiol. 2008;52(23):e143-e263. PMID: 19038677.
Bezold LI, Smith EO, Kelly K, Fournier A, Titus JL, McNamara DG. Development and validation of an echocardiographic model for predicting progression of discrete subaortic stenosis in children. Am J Cardiol. 1998;81(3):314-320. PMID: 9468074.
Gewillig M, Daenen W, Dumoulin M, Van der Hauwaert L. Rheologic genesis of discrete subvalvular aortic stenosis: a Doppler echocardiographic study. J Am Coll Cardiol. 1992;19(4):818-824. PMID: 1545077.
Darcin OT, Yagdi T, Atay Y, et al. Discrete subaortic stenosis: surgical outcomes and follow-up results. Tex Heart Inst J. 2003;30(4):286-292. PMID: 14678139.
Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890-1900. PMID: 12084585.
Freedom RM, Pelech A, Brand A, et al. The progressive nature of subaortic stenosis in congenital heart disease. Int J Cardiol. 1985;8(2):137-143. PMID: 3997051.
Serraf A, Zoghby J, Lacour-Gayet F, et al. Surgical treatment of subaortic stenosis: a seventeen-year experience. J Thorac Cardiovasc Surg. 1999;117(4):669-678. PMID: 10096960.